Tag Archives: ConforMIS

Oppenheimer Sticks to Their Buy Rating for ConforMIS (CFMS)

Oppenheimer analyst Steven Lichtman maintained a Buy rating on ConforMIS (NASDAQ: CFMS) today. The company’s shares closed yesterday at $1.28, close to its 52-week low of $0.88. According to TipRanks.com, Lichtman has currently no stars on a ranking scale of

Analysts Offer Insights on Healthcare Companies: ConforMIS (NASDAQ: CFMS) and Masimo Corp (NASDAQ: MASI)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ConforMIS (NASDAQ:CFMS) and Masimo Corp (NASDAQ:MASI) with bullish sentiments. ConforMIS (CFMS) In a report released yesterday, Ryan Zimmerman from BTIG maintained a

ConforMIS Gets a Buy Rating from BTIG

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on ConforMIS (NASDAQ: CFMS), with a price target of $3. The company’s shares closed yesterday at $1.35, close to its 52-week low of $1.15. According to TipRanks.com,

ConforMIS Got Some Good News

In a report released today, Kyle Rose from Canaccord Genuity upgraded ConforMIS (NASDAQ: CFMS) to Buy. The company’s shares closed yesterday at $1.36, close to its 52-week low of $1.15. According to TipRanks.com, Rose is a 4-star analyst with an

Analysts Offer Insights on Healthcare Companies: ConforMIS (NASDAQ: CFMS), BeiGene Ltd (NASDAQ: BGNE) and Perrigo Company plc (NYSE: PRGO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ConforMIS (NASDAQ: CFMS), BeiGene Ltd (NASDAQ: BGNE) and Perrigo Company plc (NYSE: PRGO). ConforMIS (NASDAQ: CFMS) In a report released yesterday, Kyle Rose

The CFO of ConforMIS (NASDAQ: CFMS) is Selling Shares

Yesterday, the CFO of ConforMIS (NASDAQ: CFMS), WEINER PAUL, sold shares of CFMS for $3,449. In addition to WEINER PAUL, 3 other CFMS executives reported Sell trades in the last month. The company has a one-year high of $8.61 and